204 related articles for article (PubMed ID: 38023163)
1. Choline metabolism and its implications in cancer.
Yao N; Li W; Xu G; Duan N; Yu G; Qu J
Front Oncol; 2023; 13():1234887. PubMed ID: 38023163
[TBL] [Abstract][Full Text] [Related]
2. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
3. ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.
Gokhale S; Xie P
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34202989
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.
Farolfi A; Hadaschik B; Hamdy FC; Herrmann K; Hofman MS; Murphy DG; Ost P; Padhani AR; Fanti S
Eur Urol Oncol; 2021 Oct; 4(5):714-730. PubMed ID: 33750684
[TBL] [Abstract][Full Text] [Related]
6. ATP-induced cell death: a novel hypothesis for osteoporosis.
Wang W; Zhang H; Sandai D; Zhao R; Bai J; Wang Y; Wang Y; Zhang Z; Zhang HL; Song ZJ
Front Cell Dev Biol; 2023; 11():1324213. PubMed ID: 38161333
[TBL] [Abstract][Full Text] [Related]
7. Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Li LF; Taw BB; Pu JK; Hwang GY; Lui WM; Leung GK
World Neurosurg; 2015 Oct; 84(4):1176.e5-9. PubMed ID: 26142813
[TBL] [Abstract][Full Text] [Related]
8. Choline metabolism in cancer: implications for diagnosis and therapy.
Glunde K; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2006 Nov; 6(6):821-9. PubMed ID: 17140369
[TBL] [Abstract][Full Text] [Related]
9. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
[TBL] [Abstract][Full Text] [Related]
10. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
[TBL] [Abstract][Full Text] [Related]
12. Targeting Phospholipid Metabolism in Cancer.
Cheng M; Bhujwalla ZM; Glunde K
Front Oncol; 2016; 6():266. PubMed ID: 28083512
[TBL] [Abstract][Full Text] [Related]
13. Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy.
Podo F; Paris L; Cecchetti S; Spadaro F; Abalsamo L; Ramoni C; Ricci A; Pisanu ME; Sardanelli F; Canese R; Iorio E
Front Oncol; 2016; 6():171. PubMed ID: 27532027
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of PET/CT in prostate cancer management.
Rayn KN; Elnabawi YA; Sheth N
Transl Androl Urol; 2018 Oct; 7(5):844-854. PubMed ID: 30456187
[TBL] [Abstract][Full Text] [Related]
15. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.
Inazu M
Biopharm Drug Dispos; 2014 Nov; 35(8):431-49. PubMed ID: 24532461
[TBL] [Abstract][Full Text] [Related]
16. Choline metabolism-based molecular diagnosis of cancer: an update.
Glunde K; Penet MF; Jiang L; Jacobs MA; Bhujwalla ZM
Expert Rev Mol Diagn; 2015 Jun; 15(6):735-47. PubMed ID: 25921026
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.
Utriainen M; Komu M; Vuorinen V; Lehikoinen P; Sonninen P; Kurki T; Utriainen T; Roivainen A; Kalimo H; Minn H
J Neurooncol; 2003 May; 62(3):329-38. PubMed ID: 12777086
[TBL] [Abstract][Full Text] [Related]
18. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
19. Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis.
Kwee SA; Lim J
World J Radiol; 2016 Nov; 8(11):851-856. PubMed ID: 27928466
[TBL] [Abstract][Full Text] [Related]
20. Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase α.
Grech-Sollars M; Ordidge KL; Vaqas B; Davies C; Vaja V; Honeyfield L; Camp S; Towey D; Mayers H; Peterson D; O'Neill K; Roncaroli F; Barwick TD; Waldman AD
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
